Location History:
- Chapel Hill, NC (US) (2021)
- Stony Brook, NY (US) (2024)
Company Filing History:
Years Active: 2021-2024
Title: Richard Moffitt: Innovator in Pancreatic Cancer Treatment
Introduction
Richard Moffitt is a notable inventor based in Chapel Hill, NC (US), recognized for his contributions to the field of pancreatic cancer research. He holds 2 patents that focus on innovative methods for diagnosing and treating pancreatic ductal adenocarcinoma (PDAC). His work aims to improve treatment decision-making and patient outcomes in this challenging area of oncology.
Latest Patents
Moffitt's latest patents include a "Platform and sample type independent single sample classifier for treatment decision making in pancreatic ductal adenocarcinoma cancer." This patent provides methods for identifying pancreatic cancer subtypes in a subject and outlines a process for obtaining gene expression levels for various genes. The method involves performing pair-wise comparisons of gene expression levels and calculating a Raw Score indicative of the pancreatic cancer subtype. Additionally, it includes strategies for identifying differential treatment approaches based on the subtype of PDAC.
Another significant patent is focused on "Gene-expression based subtyping of pancreatic ductal adenocarcinoma." This patent details methods for generating a prognostic and/or subtype signature for subjects with PDAC. It emphasizes determining expression levels for specific genes in PDAC cells, which aids in classifying subjects into different subtypes and identifying tailored treatment strategies.
Career Highlights
Richard Moffitt is affiliated with The University of North Carolina at Chapel Hill, where he contributes to groundbreaking research in cancer treatment. His work is pivotal in advancing the understanding of pancreatic cancer and developing innovative diagnostic tools.
Collaborations
Moffitt collaborates with esteemed colleagues such as Jen Jen Yeh and Naim Ur Rashid, enhancing the research efforts in the field of pancreatic cancer.
Conclusion
Richard Moffitt's innovative patents and research efforts significantly contribute to the advancement of pancreatic cancer treatment. His work exemplifies the importance of innovation in improving patient care and outcomes in oncology.